Assessment of Fluoxetine's Effect in Patients With Multiple System Atrophy : a Double Blind Placebo-controlled Randomized Trial

Trial Profile

Assessment of Fluoxetine's Effect in Patients With Multiple System Atrophy : a Double Blind Placebo-controlled Randomized Trial

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Apr 2015

At a glance

  • Drugs Fluoxetine (Primary)
  • Indications Multiple system atrophy
  • Focus Therapeutic Use
  • Acronyms MSA-Fluox
  • Most Recent Events

    • 11 Sep 2012 Preliminary results presented at the 16th Congress of the European Federation of Neurological Societies.
    • 29 Feb 2012 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 29 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top